Cleared Traditional

K233446 - AMC Health CareConsole

K233446 is an FDA 510(k) clearance for AMC Health CareConsole, manufactured by Amc Health. The device is a Class 2 Cardiovascular device with product code MWI cleared through the Traditional 510(k) pathway after a 344-day FDA review.

K233446 · Amc Health · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Sep 2024
Decision
344d
Days
Class 2
Risk

K233446 is an FDA 510(k) clearance for the AMC Health CareConsole. Classified as Monitor, Physiological, Patient (without Arrhythmia Detection Or Alarms) (product code MWI), Class II - Special Controls.

Submitted by Amc Health (New York, US). The FDA issued a Cleared decision on September 27, 2024 after a review of 344 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.2300 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Elevated predicate reliance profile. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all Amc Health devices

FDA 510(k) Submission Details - K233446

510(k) Number K233446 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received October 19, 2023
Decision Date September 27, 2024
Days to Decision 344 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
219d slower than avg
Panel avg: 125d · This submission: 344d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

MWI Device Classification - Class 2, Special Controls

Product Code MWI Monitor, Physiological, Patient (without Arrhythmia Detection Or Alarms)
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.2300
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - MWI Monitor, Physiological, Patient (without Arrhythmia Detection Or Alarms)

All 150
Devices cleared under the same product code (MWI) and FDA review panel - the closest regulatory comparables to K233446.
iCare APP
K243146 · Ihealth Labs, Inc. · Feb 2025
Welch Allyn Connex® Spot Monitor
K241411 · Welch Allyn, Inc. · Dec 2024
Sensinel Cardiopulmonary Management (CPM) System (ADCP1100)
K243216 · Analog Devices · Dec 2024
Happy Ring Health Monitoring System
K240236 · Happy Health, Inc. · Sep 2024
WVSM Pro (Series) (500-0030-XX)
K233354 · Athena Gtx, Inc. · Jun 2024
NeoBeat, NeoBeat Mini
K232111 · Laerdal Medical AS · Jun 2024